Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Public ClinicalTrials.gov record NCT03969420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label, Randomized, Two-stage Clinical Study of Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia Following Treatment With Venetoclax Combination Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety and efficacy of alvocidib in patients with AML who have either relapsed from or are refractory to venetoclax in combination with azacytidine or decitabine.
Study identification
- NCT ID
- NCT03969420
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 11 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 15, 2020 (Actual)
- Primary completion
- Apr 22, 2021 (Actual)
- Completion
- May 14, 2021 (Actual)
- Last update posted
- Nov 9, 2023
2020 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Community Medical Providers | Clovis | California | 93611 | — |
| City of Hope National Medical Center, City of Hope Medical Center | Duarte | California | 91010 | — |
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| University of California, San Francisco Medical Center | San Francisco | California | 94143 | — |
| Advent Health Medical Group Blood & Marrow Transplant at Orlando | Orlando | Florida | 32804 | — |
| Orlando Health, Inc, Univ of Florida Health Cancer Center | Orlando | Florida | 32806 | — |
| Indiana Blood and Marrow Translplantation - Clinic | Indianapolis | Indiana | 46237 | — |
| University of Kansas Medical Center | Westwood | Kansas | 66205 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| University of New Mexico | Albuquerque | New Mexico | 87106 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Columbia University Medical Center | New York | New York | 10027 | — |
| University of North Carolina (UNC) | Chapel Hill | North Carolina | 27599 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Oregon Health & Sciences University - Knight Cancer Institute - Center for Hematologic Malignancies | Portland | Oregon | 97239 | — |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15212 | — |
| Baylor University Center | Dallas | Texas | 75211 | — |
| University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03969420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03969420 live on ClinicalTrials.gov.